< 1 minute read
Feb. 9, 2022
Berotralstat (BCX7353): an Oral Plasma Kallikrein Inhibitor
BioCryst Kallikrein Inhibitor
oral plasma kallikrein serine protease inhibitor approved for prevention of HAE attacks from structure-based drug design berotralstat BioCryst, Birmingham, AL
Loading...
